Lai; Ching-Juh

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lai; Ching-Juh.The latest application filed is for "development of dengue virus vaccine components".

Company Profile

0.29.19

Lai; Ching-Juh - Bethesda MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Development Of Dengue Virus Vaccine Components App 20220251521 - Whitehead; Stephen S. ; et al.	2022-08-11
Development of dengue virus vaccine components Grant 11,332,722 - Whitehead , et al. May 17, 2	2022-05-17
Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein Grant 11,318,196 - Whitehead , et al. May 3, 2	2022-05-03
Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-utr Of Dengue Types 1,2,3, And 4, Or Antigenic Chimeric Dengue Viruses 1,2,3, And 4 App 20200392469 - Whitehead; Stephen S. ; et al.	2020-12-17
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4 Grant 10,837,003 - Whitehead , et al. November 17, 2	2020-11-17
Development Of Dengue Virus Vaccine Components App 20200318083 - Whitehead; Stephen S. ; et al.	2020-10-08
Development of dengue virus vaccine components Grant 10,724,007 - Whitehead , et al.	2020-07-28
Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses App 20200085939 - Whitehead; Stephen S. ; et al.	2020-03-19
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses Grant 10,500,264 - Whitehead , et al. Dec	2019-12-10
Development Of Dengue Virus Vaccine Components App 20190119654 - Whitehead; Stephen S. ; et al.	2019-04-25
Development of dengue virus vaccine components Grant 10,160,957 - Whitehead , et al. Dec	2018-12-25
Development Of Dengue Virus Vaccine Components App 20180171308 - Whitehead; Stephen S. ; et al.	2018-06-21
Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-utr Of Dengue Types 1, 2, 3, And 4, Or Antigenic Chimeric Dengue Viruses 1, 2, 3, And 4 App 20180010099 - Whitehead; Stephen S. ; et al.	2018-01-11
Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses App 20180008693 - Whitehead; Stephen S. ; et al.	2018-01-11
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 Grant RE46,641 - Whitehead , et al. December 19, 2	2017-12-19
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 Grant RE46,631 - Whitehead , et al. December 12, 2	2017-12-12
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4 Grant 9,783,787 - Whitehead , et al. October 10, 2	2017-10-10
Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use Grant 9,783,596 - Goncalvez , et al. October 10, 2	2017-10-10
Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein Grant 9,707,287 - Whitehead , et al. July 18, 2	2017-07-18
Development of dengue virus vaccine components Grant RE46,042 - Whitehead , et al. June 28, 2	2016-06-28
Humanized Monoclonal Antibodies That Specifically Bind And/or Neutralize Japanese Encephalitis Virus (jev) And Their Use App 20160137722 - Goncalvez; Ana P. ; et al.	2016-05-19
Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use Grant 9,273,121 - Goncalvez , et al. March 1, 2	2016-03-01
Development of dengue virus vaccine components Grant 9,090,873 - Whitehead , et al. July 28, 2	2015-07-28
Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses App 20150064214 - Whitehead; Stephen S. ; et al.	2015-03-05
Recombinant attenuated dengue viruses comprising a deletion in the 3' untranslated region and additional attenuating mutations induced by chemical mutagenesis Grant RE45,123 - Whitehead , et al. September 9, 2	2014-09-09
Attenuated dengue virus comprising mutations in the NS3 gene Grant RE45,053 - Whitehead , et al. July 29, 2	2014-07-29
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses Grant RE45,016 - Whitehead , et al. July 15, 2	2014-07-15
Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3' untranslated region Grant 8,632,782 - Whitehead , et al. January 21, 2	2014-01-21
Monoclonal Antibodies Against Dengue And Other Viruses With Deletion In Fc Region App 20130344058 - Goncalvez; Ana P. ; et al.	2013-12-26
Humanized Monoclonal Antibodies That Specifically Bind And/or Neutralize Japanese Encephalitis Virus (jev) And Their Use App 20130295090 - Goncalvez; Ana P. ; et al.	2013-11-07
Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus (JEV) and their use Grant 8,506,961 - Goncalvez , et al. August 13, 2	2013-08-13
Monoclonal Antibodies That Bind Or Neutralize Dengue Virus App 20130089543 - Lai; Ching-Juh ; et al.	2013-04-11
Monoclonal antibodies against dengue and other viruses with deletion in Fc region Grant 8,337,854 - Goncalvez , et al. December 25, 2	2012-12-25
Monoclonal antibodies that bind or neutralize dengue virus Grant 8,337,853 - Lai , et al. December 25, 2	2012-12-25
Humanized Monoclonal Antibodies That Specifically Bind And/or Neutralize Japanese Encephalitis Virus (jev) And Their Use App 20110033462 - Goncalvez; Ana P. ; et al.	2011-02-10
Monoclonal Antibodies That Bind Or Neutralize Dengue Virus App 20110008256 - Lai; Ching-Juh ; et al.	2011-01-13
Monoclonal Antibodies Against Dengue And Other Viruses With Deletion In Fc Region App 20100247549 - Goncalvez; Ana P. ; et al.	2010-09-30
Monoclonal antibodies that bind or neutralize dengue virus Grant 7,622,113 - Lai , et al. November 24, 2	2009-11-24
Monoclonal antibodies that bind or neutralize dengue virus App 20070134256 - Lai; Ching-Juh ; et al.	2007-06-14
Chimeric and/or growth-restricted flaviviruses Grant 6,676,936 - Lai , et al. January 13, 2	2004-01-13
Chimeric vaccine against tick-borne encephalitis virus Grant 6,660,273 - Pletnev , et al. December 9, 2	2003-12-09
Chimeric vaccine against tick-borne encephalitis virus App 20030165539 - Pletnev, Alexander ; et al.	2003-09-04
Chimeric vaccine against tick-borne encephalitis virus Grant 6,497,884 - Pletnev , et al. December 24, 2	2002-12-24
Chimeric and/or growth-restricted flaviviruses Grant 6,184,024 - Lai , et al. February 6, 2	2001-02-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.